Generic Name: Omalizumab
Brand Name: Xolair
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Indications: Asthma, severe persistent
Submission Type: New
Project Status: Cancelled
Omalizumab
Last Updated: April 18, 2005
Result type: Reports
Project Number: S0035
Product Line: Common Drug Review